CURE Pharmaceutical Receives NSF’s cGMP Certi…

OXNARD, Calif., July 08, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical, (CURR), an innovative drug delivery and development company, today announced that its 25,000 square foot manufacturing facility has earned NSF International, cGMP certification for the manufacture of dietary supplements. This…

CURE Pharmaceutical Appoints Chief Business O…

– Jonathan Berlent Appointed to Newly Created Role – OXNARD, Calif., June 16, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical, (CURR), an innovative drug delivery and development company, today named Jonathan Berlent, 51, to the newly created position of Chief Business…

CURE Pharmaceutical Announces Exercise of War…

OXNARD, Calif., June 09, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical Holding Corp. (CURR), an innovative drug delivery company that is developing novel ways to deliver active ingredients, announced today that it strengthened its balance sheet with the receipt of $1.4…

CURE Pharmaceutical Expands to Mexico in Coll…

CURE extends vitamin D, sleep and combination CBD products distribution throughout Mexico OXNARD, Calif., June 03, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, announced today a collaboration with PMI, a subsidiary of Factoria…

CURE Pharmaceutical Expands Cannabis Extracti…

Equipment manufacturers, cannabis processors and drug developers can license CURE’s patented methods for optimal extraction of cannabinoids LOS ANGELES, April 21, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced the issuance of…

CURE Pharmaceutical Secures Chinese Patent on…

ED Drug Market Expected to Reach US$6.5B by 2025 OXNARD, Calif., March 17, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced the allowance of Chinese Patent No. ZL201480039313.6. The new patent covers…

CURE Pharmaceutical Licenses Cannabis Extract…

Vanguard Scientific builds customer trust with CUREinside™ patented methods LOS ANGELES, Feb. 12, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced a licensing and collaboration agreement with Vanguard Scientific Systems, Inc., a premier…

CURE Pharmaceutical Expands to Europe, Signs …

CURE debuts “CUREinside” quality mark on the packaging of ReLeaf Europe’s sublingual tinctures and new topical cream product lines OXNARD, Calif., Feb. 05, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, announced today that…

Green Hygienics Holdings Inc. Announces Strategic Partn…

SAN DIEGO, Jan. 14, 2020 (GLOBE NEWSWIRE) — via NetworkWire — Green Hygienics Holdings Inc. (GRYN) (“GRYN” or the “Company”), an innovative premium cannabis cultivation and branding enterprise, is pleased to announce that it has secured an investment from La…

CURE Pharmaceutical to Present at the 12th An…

CURE CEO to discuss company’s expanded technology platform and pharmaceutical pipeline LOS ANGELES, Dec. 05, 2019 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced that it will be presenting at the 12th Annual…